KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) EBITDA (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed EBITDA for 17 consecutive years, with $23.2 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 143.79% to $23.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.8 million through Dec 2025, up 143.38% year-over-year, with the annual reading at $65.8 million for FY2025, 143.38% up from the prior year.
  • EBITDA hit $23.2 million in Q4 2025 for Nu Skin Enterprises, up from $21.6 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $85.4 million in Q2 2021 to a low of -$125.6 million in Q2 2024.
  • Historically, EBITDA has averaged $15.4 million across 5 years, with a median of $21.0 million in 2021.
  • Biggest YoY gain for EBITDA was 169.15% in 2024; the steepest drop was 430.46% in 2024.
  • Year by year, EBITDA stood at $20.3 million in 2021, then soared by 35.14% to $27.5 million in 2022, then tumbled by 41.5% to $16.1 million in 2023, then tumbled by 430.46% to -$53.1 million in 2024, then surged by 143.79% to $23.2 million in 2025.
  • Business Quant data shows EBITDA for NUS at $23.2 million in Q4 2025, $21.6 million in Q3 2025, and $30.8 million in Q2 2025.